Bear Mountain Capital »

Phathom Pharmaceuticals shares owned by Bear Mountain Capital

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Bear Mountain Capital from 13F filings

Historical chart of Bear Mountain Capital investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Bear Mountain Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Bear Mountain Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0k 200 9.80
2023-12-31 $1.5k 200 7.51

More positions owned by Bear Mountain Capital

Vanguard Mid Cap Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Amt-free Muni Bond Etf Etf (MUB)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Msci Eafe Small Cap Etf Etf (SCZ)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Small Cap Etf Etf (VB)
Vanguard Real Estate Etf Etf (VNQ)
Vanguard Total International Bond Etf Etf (BNDX)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Msci Usa Esg Select Etf Etf (SUSA)
Ishares Esg Aware 1-5 Year Usd Corporate Bond Etf Etf (SUSB)
Vanguard Total Stock Market Etf Etf (VTI)

View all positions for Bear Mountain Capital

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals